proline and Albuminuria

proline has been researched along with Albuminuria in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asmathulla, S; Balamurugan, R; Karthikeyan, K; Kaviraj, M; Polly, D	1
Bossi, A; De Cosmo, S; Motterlini, N; Pellegrini, F; Prudente, S; Remuzzi, G; Ruggenenti, P; Trevisan, R; Trischitta, V	1
Gilbert, RE; Kelly, DJ; Mifsud, S; Pollock, CA; Qi, W; Wilkinson-Berka, JL; Zhang, Y	1

Trials

1 trial(s) available for proline and Albuminuria

Article	Year
Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT. Diabetes, 2009, Volume: 58, Issue:12 Topics: Adult; Aged; Alanine; Albuminuria; Alleles; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Hypertension; Incidence; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Prospective Studies; Research Design; Risk Factors	2009

Article

Year

Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.

Diabetes, 2009, Volume: 58, Issue:12

Topics: Adult; Aged; Alanine; Albuminuria; Alleles; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Hypertension; Incidence; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Prospective Studies; Research Design; Risk Factors

2009

Other Studies

2 other study(ies) available for proline and Albuminuria

Article	Year
Topical proline therapy in prolidase deficiency. Clinical and experimental dermatology, 2019, Volume: 44, Issue:3 Topics: Administration, Topical; Adult; Albuminuria; Female; Humans; Prolidase Deficiency; Proline; Skin Ulcer; Treatment Outcome	2019
Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy. Nephron. Physiology, 2003, Volume: 95, Issue:4 Topics: Albuminuria; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Atrophy; Blotting, Western; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Fibroblasts; Fibronectins; Fibrosis; Humans; Immunohistochemistry; Kidney; Mice; ortho-Aminobenzoates; Proline; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Time Factors; Transforming Growth Factor beta; Tritium	2003

Article

Year

Topical proline therapy in prolidase deficiency.

Clinical and experimental dermatology, 2019, Volume: 44, Issue:3

Topics: Administration, Topical; Adult; Albuminuria; Female; Humans; Prolidase Deficiency; Proline; Skin Ulcer; Treatment Outcome

2019

Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.

Nephron. Physiology, 2003, Volume: 95, Issue:4

Topics: Albuminuria; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Atrophy; Blotting, Western; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Fibroblasts; Fibronectins; Fibrosis; Humans; Immunohistochemistry; Kidney; Mice; ortho-Aminobenzoates; Proline; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Time Factors; Transforming Growth Factor beta; Tritium

2003